Research view
Switch to patient viewCystic fibrosis: trials that stopped early
Trials on Cystic fibrosis that stopped early, each with the reason the sponsor wrote in the registry, quoted word for word. Next to them: finished trials whose registry record links a result paper.
Stopped early
21 stopped trials give a reason in the registry, latest registry update first.
Terminated
A Study to Test the Safety and Effects of Inhaled GDC-6988 in Participants With Muco-obstructive Disease
Reason given in the registry “Sponsor's Decision”
Quoted unchanged from ClinicalTrials.gov; record updated 20 Oct 2026.
- Ended
- Aug 2026
- Phase
- Phase 1
- Run by
- Genentech, Inc.
- Registry record
- NCT06603246
Suspended
A Study to Access Activity and Safety With SAR445399 Compared With Placebo in Participants Aged 18 to 80 Years of Age With Non-Cystic Fibrosis Bronchiectasis
Reason given in the registry “The pause is for strategic business reasons to facilitate internal portfolio review. The pause is not due to any concerns with patient safety, with program benefit/risk, or with trial integrity.”
Quoted unchanged from ClinicalTrials.gov; record updated 29 Jul 2026.
- Phase
- Phase 2
- Run by
- Sanofi
- Registry record
- NCT07547436
Withdrawn
Real World Environmental Exposure Study With Healthy and Cystic Fibrosis Subjects
Reason given in the registry “Significant difficulties in recruiting participants, particularly in the 'cystic fibrosis' group.The constraints placed on participants, in particular the requirement to walk for ten days (5 days in an urban area and 5 days in a green area)”
Quoted unchanged from ClinicalTrials.gov; record updated 16 Jun 2026.
- Run by
- Centre Hospitalier Intercommunal Creteil
- Registry record
- NCT06339450
Terminated
MR Imaging of Lung in the Follow-up Assessment of Cystic Fibrosis
Reason given in the registry “Target number of inclusion not reached”
Quoted unchanged from ClinicalTrials.gov; record updated 9 Jun 2026.
- Ended
- Mar 2025
- Run by
- University Hospital, Bordeaux
- Registry record
- NCT03357562
Withdrawn
Effects of AD on VI in Patients With CF
Reason given in the registry “No recruitement, no grant to support this study”
Quoted unchanged from ClinicalTrials.gov; record updated 29 Apr 2026.
- Ended
- Dec 2025
- Run by
- Cliniques universitaires Saint-Luc- Université Catholique de Louvain
- Registry record
- NCT03655249
Terminated
Epidemiology and Clinical Characteristics of Non-Tuberculous Mycobacteria Infections in Cystic Fibrosis Patients.
Reason given in the registry “The pace of patient enrollment was significantly affected by the COVID-19 pandemic. Since this is an epidemiological study that does not require a specific number of patients to meet the primary objective, the enrollment period was not extended.”
Quoted unchanged from ClinicalTrials.gov; record updated 20 Mar 2026.
- Ended
- Jun 2024
- Run by
- University Hospital, Brest
- Registry record
- NCT03312075
Terminated
Diagnosis and Treatment of Patients With Cystic Fibrosis
Reason given in the registry “PI left NIH”
Quoted unchanged from ClinicalTrials.gov; record updated 4 Feb 2026.
- Ended
- Jan 2026
- Run by
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- Registry record
- NCT00001223
Suspended
Genomic Resources for Enhancing Available Therapies (GREAT1.0) Study
Reason given in the registry “Suspended for analysis and to consider further enrollment.”
Quoted unchanged from ClinicalTrials.gov; record updated 7 Jan 2026.
- Run by
- University of Pittsburgh
- Registry record
- NCT04306939
Terminated
Frequency-time Analysis of Pathological Lung Sounds: Detection and Quantification of Pathological Sounds in Patients With Cystic Fibrosis, Pulmonary Fibrosis or COPD (Chronic Obstructive Pulmonary Disease)
Reason given in the registry “Recruitment issue”
Quoted unchanged from ClinicalTrials.gov; record updated 17 Nov 2025.
- Ended
- Aug 2025
- Run by
- Groupe Hospitalier de la Region de Mulhouse et Sud Alsace
- Registry record
- NCT06399094
Terminated
Validation of Therapeutic Efficacy Targeting the Splicing Variants in Cystic Fibrosis and CFTR Pathologies
Reason given in the registry “Enrolment period completed and sufficient number of enrolments to achieve study objectives”
Quoted unchanged from ClinicalTrials.gov; record updated 18 Sept 2025.
- Ended
- Feb 2025
- Run by
- University Hospital, Montpellier
- Registry record
- NCT05100823
Terminated
Efficacy and Safety of Benralizumab in Patients With Non-cystic Fibrosis Bronchiectasis
Reason given in the registry “Due to the decision to stop recruitment early, enrolment into the MAHALE trial was terminated in August 2022; 139 patients were screened and 100 randomised to IP.”
Quoted unchanged from ClinicalTrials.gov; record updated 20 Jul 2025.
- Ended
- Apr 2024
- Phase
- Phase 3
- Run by
- AstraZeneca
- Registry record
- NCT05006573
Withdrawn
Rifaximin for Treatment of Bloating in Children and Adults With Cystic Fibrosis
Reason given in the registry “new drug formulation by the manufacturer”
Quoted unchanged from ClinicalTrials.gov; record updated 27 Jun 2025.
- Ended
- Sept 2025
- Phase
- Phase 2/3
- Run by
- Wake Forest University Health Sciences
- Registry record
- NCT05408910
Terminated
Effect of Postprandial Insulin Administration of Faster-acting Insulin Analogue Versus Pre-prandial Administration of Acting-insulin Analogue in Cystic Fibrosis Related Diabetes
Reason given in the registry “Difficulties of inclusion in this rare pathology”
Quoted unchanged from ClinicalTrials.gov; record updated 5 Mar 2025.
- Ended
- Jan 2025
- Phase
- Phase 4
- Run by
- University Hospital, Strasbourg, France
- Registry record
- NCT04381429
Terminated
Imipenem/Cilastatin/Relebactam Pharmacokinetics, Safety, and Outcomes in Adults and Adolescents With Cystic Fibrosis
Reason given in the registry “Difficulty enrolling”
Quoted unchanged from ClinicalTrials.gov; record updated 17 Dec 2024.
- Ended
- Dec 2024
- Phase
- Phase 4
- Run by
- Hartford Hospital
- Registry record
- NCT05561764
Terminated
Symptom Based Performance of Airway Clearance After Starting Highly Effective Modulators for Cystic Fibrosis (SPACE-CF)
Reason given in the registry “Low recruitment, low interest from participant population”
Quoted unchanged from ClinicalTrials.gov; record updated 20 Sept 2024.
- Ended
- Sept 2024
- Run by
- University of Missouri-Columbia
- Registry record
- NCT05392855
Terminated
A Pilot Study to Evaluate the Use of the Vest® System for Treatment of Bronchiectasis Patients in the Home Setting
Reason given in the registry “Data”
Quoted unchanged from ClinicalTrials.gov; record updated 21 Aug 2024.
- Ended
- Aug 2024
- Run by
- Hill-Rom
- Registry record
- NCT04017312
Terminated
Study of a Nebulised Nitric Oxide Generating Solution in Patients With Mycobacterium Abscessus
Reason given in the registry “TSC recommended early termination due to lack of futility of the trial.”
Quoted unchanged from ClinicalTrials.gov; record updated 10 May 2024.
- Ended
- Apr 2024
- Phase
- Phase 2
- Run by
- Papworth Hospital NHS Foundation Trust
- Registry record
- NCT05101915
Withdrawn
Hepatitis B in Cystic Fibrosis and Latent Tuberculosis Respectively
Reason given in the registry “Time and resource deficiency at the Stockholm CF Center.”
Quoted unchanged from ClinicalTrials.gov; record updated 18 Mar 2024.
- Ended
- Dec 2025
- Run by
- Karolinska University Hospital
- Registry record
- NCT02605538
Withdrawn
A Study of Inhaled KB407 for the Treatment of Cystic Fibrosis
Reason given in the registry “Pandemic, logistical, and recruitment challenges”
Quoted unchanged from ClinicalTrials.gov; record updated 14 Aug 2023.
- Ended
- Oct 2024
- Phase
- Phase 1
- Run by
- Krystal Biotech, Inc.
- Registry record
- NCT05095246
Withdrawn
Relationship Between the Development of Impaired Glucose Tolerance, the Phenotype of CFLD, and the Risk of Liver Fibrosis
Reason given in the registry “No participants enrolled”
Quoted unchanged from ClinicalTrials.gov; record updated 13 Jul 2023.
- Ended
- Dec 2023
- Run by
- Dartmouth-Hitchcock Medical Center
- Registry record
- NCT05229640
Withdrawn
Human MesenchymAl Stem Cells Infusion in Patients With Cystic Fibrosis
Reason given in the registry “PI left the institution”
Quoted unchanged from ClinicalTrials.gov; record updated 13 May 2020.
- Phase
- Phase 1
- Run by
- Joshua M Hare
- Registry record
- NCT03058068
Sources: ClinicalTrials.gov and the EU Clinical Trials Register. Status, reason, dates and result links are registry fields, shown as the registry gives them.